HomeRDPTF • OTCMKTS
add
Radiopharm Theranostics Ltd
Previous close
$0.020
Year range
$0.020 - $0.020
Market cap
85.59M AUD
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.10M | 154.52% |
Operating expense | 4.95M | 40.63% |
Net income | -13.48M | -44.00% |
Net profit margin | -434.67 | 43.42% |
Earnings per share | — | — |
EBITDA | -12.47M | -36.33% |
Effective tax rate | -0.48% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.52M | -5.27% |
Total assets | 91.17M | -1.38% |
Total liabilities | 41.23M | 1.94% |
Total equity | 49.94M | — |
Shares outstanding | 3.54B | — |
Price to book | 2.00 | — |
Return on assets | -36.04% | — |
Return on capital | -65.80% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.48M | -44.00% |
Cash from operations | -11.34M | -2.05% |
Cash from investing | -2.66M | -6,668.05% |
Cash from financing | 16.72M | -15.40% |
Net change in cash | 2.70M | -69.78% |
Free cash flow | -6.80M | -56.45% |
About
Founded
2021
Website
Employees
14
